<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BIORXIV</journal-id>
<journal-title-group>
<journal-title>bioRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/191064</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="author-type">
<subject>Regular Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>New Results</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Cancer Biology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Curated compendium of human transcriptional biomarker data</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Golightly</surname>
<given-names>Nathan P.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bischoff</surname>
<given-names>Anna I.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bell</surname>
<given-names>Avery</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hollingsworth</surname>
<given-names>Parker D.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Piccolo</surname>
<given-names>Stephen R.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Department of Biology, Brigham Young University</institution>, Provo, Utah, 84602, <country>USA</country></aff>
<aff id="a2"><label>2</label><institution>Northeast Ohio Medical University</institution>, Rootstown, Ohio, 44272, <country>USA</country></aff>
<aff id="a3"><label>3</label><institution>Department of Biomedical Informatics, University of Utah</institution>, Salt Lake City, Utah, 84602, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Please address correspondence to S.R.P. at <email>stephen_piccolo@byu.edu</email>.</corresp>
</author-notes>
<pub-date pub-type="epub">
<year>2017</year>
</pub-date>
<elocation-id>191064</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>9</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>19</day>
<month>9</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>9</month>
<year>2017</year>
</date>
</history><permissions><copyright-statement>&#x00A9; 2017, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2017</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license></permissions>
<self-uri xlink:href="191064.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract><title>Abstract</title>
<p>Genome-wide transcriptional profiles provide broad insights into cellular activity. One important use of such data isto identify relationships between transcription levels and patient outcomes. These translational insights can guide the development of biomarkers for predicting outcomes in clinical settings. Over the past decades, data from many translational-biomarker studies have been deposited in public repositories, enabling other scientists to reuse the data in follow-up studies. However, data-reuse efforts require considerable time and expertise because transcriptional data are generated using heterogeneous profiling technologies, preprocessed using diverse normalization procedures, and annotated in non-standard ways. To address this problem, we curated a compendium of 45 translational-biomarker datasets from the public domain. To increase the data&#x2019;s utility, we reprocessed the raw expression data using a standard computational pipeline and standardized the clinical annotations in a fully reproducible manner (see <ext-link ext-link-type="uri" xlink:href="https://osf.io/ssk3t">osf.io/ssk3t</ext-link>). We believe these data will be particularly useful to researchers seeking to validate gene-level findings or to perform benchmarking studies&#x2014;for example, to compare and optimize machine-learning algorithms&#x2019; ability to predict biomedical outcomes.</p>
</abstract>
<counts>
<page-count count="31"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1"><title>Background&#x0026;summary</title>
<p>DNA encodes a cell&#x2019;s instruction manual in the form of genes and regulatory sequences<sup><xref ref-type="bibr" rid="c1">1</xref></sup>. Cells behave differently, in part, because genes are transcribed into RNA at different levels within those cells<sup><xref ref-type="bibr" rid="c2">2</xref></sup>. Researchers examine gene-expression levels to understand cellular dynamics and the mechanisms behind cellular aberrations, including those that lead to disease development. Modern technologies now make it possible to profile expression levels for thousands of genes at a time for a modest expense<sup><xref ref-type="bibr" rid="c3">3</xref></sup>. Using these high-throughput technologies, scientists have performed thousands of studies to characterize biological processes and to evaluate the potential for precision-medicine applications. One such application is to derive <italic>transcriptional biomarkers</italic>&#x2014;patterns of expression that indicate disease states or that predict medical outcomes, such as relapse, survival, or treatment response<sup><xref ref-type="bibr" rid="c4">4</xref>&#x2013;<xref ref-type="bibr" rid="c10">10</xref></sup>. Indeed, already to date, more than 100 transcriptional biomarkers have been proposed for predicting breast-cancer survival alone<sup><xref ref-type="bibr" rid="c11">11</xref></sup>.</p>
<p>Many funding agencies and academic journals have imposed policies that require scientists to deposit transcriptional data in publicly accessible databases. These policies seek to ensure that other scientists can verify the original study&#x2019;s findings and can reuse the data in secondary analyses. For example, Gene Expression Omnibus (GEO) currently contains data for more than 2 million biological samples<sup><xref ref-type="bibr" rid="c12">12</xref></sup>. Upon considering infrastructure and personnel costs, we estimate that these data represent hundreds of millions&#x2014;if not billions&#x2014;of dollars (USD) of collective research investment. Reusing these vast resources offers an opportunity to reap a greater return on investment&#x2014;perhaps most importantly via informing and validating new studies. Unfortunately, although anyone can access GEO data, researchers vastly underutilize this treasure trove because preparing data for new analyses requires considerable background knowledge and informatics expertise.</p>
<p>In GEO, data are typically available in two forms: 1) raw data, as produced originally by the data-generating technology, and 2) processed data, which were used in the data generators&#x2019; analyses. In most cases, researchers process raw data in a series of steps that might include quality-control filtering, noise reduction, standardization, and summarization (e.g., summarizing to gene-level values and excluding outliers). Data from different profiling technologies must be handled in ways that are specific to each technology. However, even for datasets generated using the same profiling technology, the methods employed for data preprocessing vary widely across studies. This heterogeneity makes it difficult for researchers to perform secondary analyses and to trust that analytical findings are driven primarily by biological mechanisms rather than differences in data preprocessing. In addition, when data have not been mapped to biologically meaningful identifiers, it may be difficult for researchers to draw biological conclusions from the data.</p>
<p>Sample-level annotations accompany each GEO dataset. For biomarker studies, such metadata might include medical diagnoses or treatment outcomes, as well as covariates such as age, sex, or ethnicity. Although GEO publishes metadata in a semi-standardized format and bioinformatics tools exist for downloading and parsing GEO data<sup><xref ref-type="bibr" rid="c13">13</xref>,<xref ref-type="bibr" rid="c14">14</xref></sup>, it is difficult for many researchers to extract these data into a form that is suitable for secondary analyses. Within annotation files, values are often stored in key/value pairs with nondescript column names. Many columns are not useful for analytical purposes (e.g., when all samples have the same value). When values are missing, the columns often become shifted; accordingly, data for a given variable may be spread across multiple columns. Moreover, a variety of descriptors (e.g., &#x201C;&#x003F;&#x201D;, &#x201C;N/A&#x201D;, or &#x201C;Unknown&#x201D;) are used to indicate missing values,thus requiring the analyst to account for these differences. In addition, seemingly minor errors, such as spelling mistakes or inconsistent capitalization, can hamper secondary-analysis efforts.</p>
<p>In response to these challenges, we compiled the <italic>Biomarker Benchmark</italic>, a curated compendium of 45 transcriptional-biomarker datasets from GEO. These datasets represent a variety of human-disease states and outcomes, many related to cancer. We obtained raw gene-expression files, renormalized them using a common algorithm, and summarized the data using gene-level annotations (<xref ref-type="fig" rid="fig1">Figure 1</xref>). We used two techniques to check for quality-control issues in the gene-expression data. For datasets where gene-expression data were processed in multiple batches&#x2014;and where batch information was available&#x2014;we corrected for batch effects. Finally, we prepared a version of the data that is suitable for direct application in machine-learning analyses. We standardized continuous values, one-hot encoded discrete values, and imputed missing values.</p>
<fig id="fig1" position="float" fig-type="figure"><label>Fig. 1.</label>
<caption><title>Flow diagram that illustrates the process we used to collect and curate the data.</title> <p>We wrote computer scripts that downloaded the data, checked for quality, normalized and standardized data values, and stored the data in analysis-ready file formats. The specific steps differed for clinical and expression data (see Methods).</p></caption>
<graphic xlink:href="191064_fig1.tif"/>
</fig>
</sec>
<sec id="s2"><title>Methods</title>
<sec id="s2a"><title>Selecting data</title>
<p>To select datasets, we executed a custom search in Gene Expression Omnibus (GEO). First, we limited our search to data series that were associated with the Medical Subject Heading (MeSH) term &#x0022;biomarker&#x0022; and that came from <italic>Homo sapiens</italic> subjects. Next we limited the search to data generated using Affymetrix gene-expression microarrays and for which raw expression data were available (so we could renormalize the data). For each dataset, we examined the metadata to ensure that each series had at least one biomarker-relevant clinical variable. These included variables such as prognosis, disease stage, histology, and treatment success or relapse. Lastly, we selected series that included data for at least 70 samples (before additional filtering, see below).</p>
<p>Based on these criteria, we identified 36 GEO series. Two series (GSE6532 and GSE26682) contained data for two types of Affymetrix microarray. To avoid platform-related biases, we separated each of these series into two datasets; we useda suffix for each that indicates the microarray platform (e.g., GSE6532_U133A and GSE6532_U133Plus2). For both of these datasets, the biological samples profiled using either microarray platform were distinct. The GSE2109 series&#x2014;known as the Expression Project for Oncology (expO)&#x2014;had been produced by the International Genomics Consortium and contains data for 129 different cancer types. To avoid confounding effects due to tissue-specific expression and because the metadata differed considerably across the cancer types, we split GSE2109 into multiple datasets based on cancer type (<xref ref-type="table" rid="tbl1">Table 1</xref>). We excluded tissue types for which fewer than 70 samples were available; we also excluded the &#x201C;omentum&#x201D; cancer type because it was relatively heterogeneous and had relatively few samples.</p>
<p>We used publicly available data for this study and played no role in contacting the research subjects. We received approval to work with these data from Brigham Young University&#x2019;s Institutional Review Board (E 14522).</p>
<table-wrap id="tbl1" orientation="portrait" position="float"><label>Table 1.</label>
<caption><p>Overview of data sources used in this study.</p></caption>
<graphic xlink:href="191064_tbl1.tif"/>
<graphic xlink:href="191064_tbl1a.tif"/>
<graphic xlink:href="191064_tbl1b.tif"/>
<graphic xlink:href="191064_tbl1c.tif"/>
<graphic xlink:href="191064_tbl1d.tif"/>
</table-wrap>
</sec>
<sec id="s2b"><title>Preparing clinical annotations</title>
<p>For each dataset, we wrote custom R scripts <sup><xref ref-type="bibr" rid="c15">15</xref></sup> that download, parse, and reformat the clinical annotations. Initially, these scripts download data using the <italic>GEOquery</italic> package <sup><xref ref-type="bibr" rid="c13">13</xref></sup>. Next they generate a tab-delimited text file for each dataset that contains all available clinical annotations, except those with identical values for all samples (for example, platform name, species name, submission date) or that were unique to each biological sample (for example, sample title). In addition, these scripts generate Markdown files <ext-link ext-link-type="uri" xlink:href="http://daringfireball.net/projects/markdown/syntax">daringfireball.net/projects/markdown/syntax</ext-link> that summarize each dataset and indicate sources.</p>
<p>In some cases, multiple data values are included in the same cell in GEO annotation files. For example, in GSE5462, one patient&#x2019;s clinical demographics and treatment responses are listed as &#x0022;female;breast tumor;Letrozole, 2.5mg/day,oral,10-14 days; responder.&#x0022; We parsed these values and split them into separate columns for each sample. After these cleaning steps, the datasets contained 7.8 variables of metadata, on average ( <xref ref-type="table" rid="tbl1">Table 1</xref>). Next we searched each dataset for missing values. Across the datasets, 11 distinct expressions had been used by the original data generators to represent missingness; these included &#x0022;N/A&#x0022;, &#x0022;NA&#x0022;,&#x0022;MISSING&#x0022;, &#x0022;NOT AVAILABLE&#x0022;, &#x0022;&#x003F;&#x0022;, and others. To support consistency, we standardized these values across the datasets, using a value of &#x0022;NA&#x0022;. On average, 17.0&#x0025; of the metadata values were missing per dataset; this proportion differed considerably across the datasets (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p>
<fig id="fig2" position="float" fig-type="figure"><label>Fig. 2.</label>
<caption><title>Histogram showing the proportion of missing clinical-annotation values per dataset.</title><p>Some datasets contained no missing values, while others were missing as many as as 72.3&#x0025; of data values.</p></caption>
<graphic xlink:href="191064_fig2.tif"/>
</fig>
<p>We anticipate that many researchers will use these data to develop and benchmark machine-learning algorithms. Accordingly, we have prepared secondary versions of the clinical annotations that are ready to use in machine-learning analyses. First, we identified class variables that have potential relevance for biomarker applications. In many cases, these variables were identical to those used in the original studies; we also included class variables that had not been used in the original studies. On average, the datasets contain 2.9 class variables. Second, we identified clinical variables that could be used as predictor variables (or covariates). Using these data, we generated one output file per class variable or predictor variable and named the output files using descriptive prefixes (e.g., &#x0022;Prognosis&#x0022;, &#x0022;Diagnosis&#x0022;, or &#x0022;Stage&#x0022;). The same variable can be used as a class variable in one context and a predictor in a different context. When a given sample was missing data for a given class variable, we excluded that sample from the respective output file for that class variable. After this filtering step, we identified class variables with fewer than 40 samples and excluded these class variables. When predictor variables were missing more than 20&#x0025; data (<xref ref-type="fig" rid="fig2">Figure 2</xref>), we did not generate an output file for these variables. When predictor variables were missing less than 20&#x0025; data, we imputed missing values using median-based imputation for continuous variables and mode-based imputation for discrete variables<sup><xref ref-type="bibr" rid="c16">16</xref></sup>. We scaled continuous predictor variables to have zero mean and unit variance. We transformed discrete predictor variables using one-hot encoding; each unique value, except the first, was treated as a binary variable. In cases where discrete values were rare, we merged values. For example, in GSE2109_Breast, we merged <italic>Pathological_Stage</italic> values 3A, 3B, 3C, and 4 into a category called &#x201C;3-4&#x201D; because relatively few patients fell into the individual categories (38, 8, 22, and 5 samples, respectively). In addition, some class variables were ordinal in nature (e.g., cancer stage or tumor grade); we transformed these to binary variables. Finally, some clinical outcomes were survival or relapse times; we transformed these data to (discrete) class variables, using a threshold to distinguish between &#x0022;long-term&#x0022; and &#x0022;short-term&#x0022; survivors and excluding patients who were censored after the survival threshold had been reached. Our computer scripts (see <italic>Code availability</italic>) encode these decisions for each dataset.</p>
</sec>
<sec id="s2c"><title>Preprocessing gene-expression data</title>
<p>We created a computational pipeline (using R and shell scripts) that downloads, normalizes, and standardizes the raw-expression data. We used the <italic>GEOquery</italic> package<sup><xref ref-type="bibr" rid="c13">13</xref></sup> to download the CEL files and then normalized them using the <italic>SCAN.UPC</italic> package<underline><sup>17</sup></underline>. Some heterogeneity exists even among platforms from the same manufacturer (Affymetrix). The number of probes and the probe sequences used in designing the microarray architectures vary. To help mitigate this heterogeneity and to aid in biological interpretation, we summarized the data using gene-level annotations from <italic>Brainarray</italic><sup><xref ref-type="bibr" rid="c18">18</xref></sup></p>
</sec>
<sec id="s2d" sec-type="data-availability"><title>Code availability</title>
<p>Our computer scripts are stored in the open-access <italic>Biomarker Benchmark</italic> repository (<ext-link ext-link-type="uri" xlink:href="https://osf.io/ssk3t">osf.io/ssk3t</ext-link>). Accordingly, other researchers can reproduce our curation process and produce alternative versions of the data.</p>
</sec>
</sec>
<sec id="s3"><title>Data records</title>
<p>After filtering (see Methods), we collected data for 7,037 biological samples across 45 datasets (<xref ref-type="table" rid="tbl1">Table 1</xref>). On average, the data sets contain values for 18,043 genes (<xref ref-type="table" rid="tbl1">Table 1</xref>). In total, our repository contains 129 class variables (2.8 per dataset) and 2.1 unique values per class variable.</p>
<p>All output data are stored in tab-delimited text files and are structured using the &#x201C;tidy data&#x201D; methodology<sup><xref ref-type="bibr" rid="c19">19</xref></sup>. Accordingly, data users can import the files directly into analytical tools such as Microsoft Excel, R, or Python. All data files are publicly and freely available in the open-access <italic>Biomarker Benchmark</italic> repository (<ext-link ext-link-type="uri" xlink:href="http://osf.io/ssk3t">osf.io/ssk3t"></ext-link>). The original data files are available via Gene Expression Omnibus using the accession numbers listed in<xref ref-type="table" rid="tbl1">Table 1</xref>.</p>
</sec>
<sec id="s4"><title>Technical validation</title>
<p>We evaluated each sample using the <italic>IQRray</italic><sup><xref ref-type="bibr" rid="c20">20</xref></sup> software, which produces a quality score for individual samples. Using these metrics, we applied Grubb&#x2019;s statistical test (<italic>outliers</italic> package<sup><xref ref-type="bibr" rid="c21">21</xref></sup>) to each dataset, identified poor-quality outliers (<xref ref-type="fig" rid="fig3">Figure 3</xref>), and excluded these samples (<xref ref-type="table" rid="tbl2">Table 2</xref>). Next we used the <italic>DoppelgangR</italic> package<sup><xref ref-type="bibr" rid="c22">22</xref></sup> to identify samples that may have been duplicated inadvertently. We manually reviewed sample pairs that <italic>DoppelgangR</italic> flagged as potential duplicates. We excluded most sample pairs that were flagged (<xref ref-type="table" rid="tbl2">Table 2</xref>), even if the clinical annotations for both samples were distinct, under the assumption that these samples had somehow been mislabeled. In GSE46449, many samples were biological replicates, and we retained one of each replicate set. GSE5462, GSE19804, and GSE20181 contained samples that had been profiled in a paired manner (e.g., pre-and post-treatment); we retained these samples.</p>
<fig id="fig3" position="float" fig-type="figure"><label>Fig. 3.</label>
<caption><title>Distribution of IQRay quality scores for each dataset.</title><p>Sample qualities are plotted for each dataset. Low-quality samples were identified using Grubb&#x2019;s test. Samples that fall on or below the red threshold were excluded from the data repository.</p></caption>
<graphic xlink:href="191064_fig3.tif"/>
</fig>
<table-wrap id="tbl2" orientation="portrait" position="float"><label>Table 2.</label>
<caption><p>Summary of excluded samples. We excluded samples that did not pass our quality-control criteria or that appeared to be duplicated. The Gene Expression Omnibus seriesand sample identifiers are listed, along with the reason we excluded each sample.</p></caption>
<graphic xlink:href="191064_tbl2.tif"/>
<graphic xlink:href="191064_tbl2a.tif"/>
<graphic xlink:href="191064_tbl2b.tif"/>
<graphic xlink:href="191064_tbl2c.tif"/>
<graphic xlink:href="191064_tbl2d.tif"/>
<graphic xlink:href="191064_tbl2e.tif"/>
<graphic xlink:href="191064_tbl2f.tif"/>
</table-wrap>
<p>When transcriptomic data are processed in multiple batches, batch assignments can lead to confounding effects<sup><xref ref-type="bibr" rid="c23">23</xref></sup>. In the clinical annotations, we identified batch-processing information for datasets GSE25507, GSE37199, GSE39582, and GSE40292. We corrected for batch effects using the ComBat software<sup><xref ref-type="bibr" rid="c24">24</xref></sup>. The <italic>Biomarker Benchmark</italic> repository contains pre-and post-batch-corrected data. For dataset GSE37199, we identified two variables that could have been used for batch correction (&#x0022;Centre&#x0022; and &#x0022;Plate&#x0022;). Our repository contains batch-corrected data for both of these batch variables (the default is &#x0022;Plate&#x0022;).</p>
</sec>
</body><back><ack><title>Acknowledgements</title>
<p>SRP thanks Brigham Young University for research funds used in this study. AIB and PDH thank the BYU Office of Research and Creative Activities for research funds that supported this work. NPG thanks the Simmons Center for Cancer Research at Brigham Young University for a summer fellowship that supported this work. We thank researchers from many institutions who generated these data and released them to the public. We also thank the many research participants who participated in these studies.</p>
</ack>
<sec><title>Author contributions</title>
<p>NPG: Collected data, wrote computer scripts, evaluated data quality, prepared figures and tables, wrote the manuscript.</p>
<p>AIB: Collected data, wrote computer scripts, evaluated data quality, edited the manuscript.</p>
<p>AB: Wrote computer scripts, wrote the manuscript.</p>
<p>PDH: Collected data, wrote computer scripts, edited the manuscript.</p>
<p>SRP: Collected data, wrote computer scripts, prepared figures and tables, wrote the manuscript.</p>
</sec>
<sec sec-type="COI-statement"><title>Competing interests</title>
<p><named-content content-type="COI-statement">The author(s) declare no competing financial interests.</named-content></p>
</sec>
<ref-list><title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Gerstein</surname>, <given-names>M. B.</given-names></string-name> <etal>et al.</etal> <article-title>What is a gene, post-ENCODE? History and updated definition</article-title>. <source>Genome Res</source>. <volume>17</volume>, <fpage>669</fpage>&#x2013;<lpage>681</lpage> (<year>2007</year>).</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Alberts</surname>, <given-names>B.</given-names></string-name> <article-title>Molecular Biology of the Cell: Reference edition</article-title>. (<source>Garland Science</source>, <year>2008</year>).</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Butte</surname>, <given-names>A.</given-names></string-name> <article-title>The use and analysis of microarray data</article-title>. <source>Nat. Rev. Drug Discov</source>. <volume>1</volume>, <fpage>951</fpage>&#x2013;<lpage>960</lpage> (<year>2002</year>).</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Piccolo</surname>, <given-names>S. R.</given-names></string-name> <etal>et al.</etal> <article-title>Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility</article-title>. <source>BMC Med. Genomics</source> <volume>8</volume>, <fpage>72</fpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Piccolo</surname>, <given-names>S. R.</given-names></string-name> &#x0026; <article-title>Frey, L. J. Clinical and molecular models of glioblastoma multiforme survival</article-title>. <source>Int. J. Data Min. Bioinform.</source> <volume>7</volume>, <fpage>245</fpage>&#x2013;<lpage>265</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Beane</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal> <article-title>Characterizing the Impact of Smoking and Lung Cancer on the Airway Transcriptome Using RNA-Seq</article-title>. <source>Cancer Prev. Res</source>. <volume>4</volume>, <fpage>803</fpage>&#x2013;<lpage>817</lpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Roychowdhury</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal> <article-title>Personalized oncology through integrative high-throughput sequencing: a pilot study</article-title>. <source>Sci. Transl. Med</source>. <volume>3</volume>, <fpage>111</fpage>ra<lpage>121</lpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Byers</surname>, <given-names>L. A.</given-names></string-name> <etal>et al.</etal> <article-title>An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance</article-title>. <source>Clin. Cancer Res</source>. <volume>19</volume>, <fpage>279</fpage>&#x2013;<lpage>290</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Adib</surname>, <given-names>T. R.</given-names></string-name> <etal>et al.</etal> <article-title>Predicting biomarkers for ovarian cancer using gene-expression microarrays</article-title>. <source>Br. J. Cancer</source> <volume>90</volume>, <fpage>686</fpage>&#x2013;<lpage>692</lpage></mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Sirota</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal> <article-title>Discovery and preclinical validation of drug indications using compendia of public gene expression data</article-title>. <source>Sci. Transl. Med</source>. <volume>3</volume>, <fpage>96</fpage>ra<lpage>77</lpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Tofigh</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal> <article-title>The prognostic ease and difficulty of invasive breast carcinoma</article-title>. <source>Cell Rep</source>. <volume>9</volume>, <fpage>129</fpage>&#x2013;<lpage>142</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Barrett</surname>, <given-names>T.</given-names></string-name> <etal>et al.</etal> <article-title>NCBI GEO: archive for functional genomics data sets-10 years on</article-title>. <source>Nucleic Acids Res</source>. <volume>39</volume>, <fpage>D1005</fpage>&#x2013;<lpage>10</lpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Davis</surname>, <given-names>S.</given-names></string-name> &#x0026; <string-name><surname>Meltzer</surname>, <given-names>P. S.</given-names></string-name> <article-title>GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor</article-title>. <source>Bioinformatics</source> <volume>23</volume>, <fpage>1846</fpage>&#x2013;<lpage>1847</lpage> (<year>2007</year>).</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Dumas</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Gargano</surname>, <given-names>M. A.</given-names></string-name> &#x0026; <string-name><surname>Dancik</surname>, <given-names>G. M.</given-names></string-name> <article-title>shinyGEO: a web-based application for analyzing gene expression omnibus datasets</article-title>. <source>Bioinformatics</source> <volume>32</volume>, <fpage>3679</fpage>&#x2013;<lpage>3681</lpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="website"><string-name><surname>Gentleman</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ihaka</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Bates</surname>, <given-names>D.</given-names></string-name> &#x0026; <collab>Others</collab>. <article-title>The R project for statistical computing</article-title>. <source>R home web site</source>:<ext-link ext-link-type="uri" xlink:href="http://www.r-project.org">www.r-project.org></ext-link> (<year>1997</year>).</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Bischl</surname>, <given-names>B.</given-names></string-name> <etal>et al.</etal> <article-title>mlr: Machine Learning in R</article-title>. <source>J. Mach. Learn. Res</source>. <volume>17</volume>, <fpage>1</fpage>&#x2013;<lpage>5</lpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Piccolo</surname>, <given-names>S. R.</given-names></string-name> <etal>et al.</etal> <article-title>A single-sample microarray normalization method to facilitate personalized-medicine workflows</article-title>. <source>Genomics</source> <volume>100</volume>, <fpage>337</fpage>&#x2013;<lpage>344</lpage> (<year>2012</year>).</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Dai</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal> <article-title>Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data</article-title>. <source>Nucleic Acids Res</source>. <volume>33</volume>, <fpage>e175</fpage> (<year>2005</year>).</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Wickham</surname>, <given-names>H.</given-names></string-name> <article-title>Tidy Data</article-title>. <source>J. Stat. Softw</source>. <volume>59</volume>, (<year>2014</year>).</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Rosikiewicz</surname>, <given-names>M.</given-names></string-name> &#x0026; <string-name><surname>Robinson-Rechavi</surname>, <given-names>M.</given-names></string-name> <article-title>IQRray, a new method for Affymetrix microarray quality control, and the homologous organ conservation score, a new benchmark method for quality control metrics</article-title>. <source>Bioinformatics 30</source>, <fpage>1392</fpage>&#x2013;<lpage>1399</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="website"><article-title>CRAN - Package outliers</article-title>. <source>Available at</source> <ext-link ext-link-type="uri" xlink:href="http://CRAN.R-project.org/package=outliers">CRAN.R-project.org/package=outliers</ext-link> (<date-in-citation>Accessed: 14th September 2017</date-in-citation>)</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Waldron</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Riester</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Ramos</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Parmigiani</surname>, <given-names>G.</given-names></string-name> &#x0026; <string-name><surname>Birrer</surname>, <given-names>M.</given-names></string-name> <article-title>The Doppelg&#x00E4;nger Effect: Hidden Duplicates in Databases of Transcriptome Profiles</article-title>. <source>J. Natl. Cancer Inst</source>. <fpage>108</fpage>, (<year>2016</year>).</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Leek</surname>, <given-names>J. T.</given-names></string-name> <etal>et al.</etal> <article-title>Tackling the widespread and critical impact of batch effects in high-throughput data</article-title>. <source>Nat. Rev. Genet</source>. <volume>11</volume>, <fpage>733</fpage>&#x2013;<lpage>739</lpage> (<year>2010</year>).</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Johnson</surname>, <given-names>W. E.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>C.</given-names></string-name> &#x0026; <string-name><surname>Rabinovic</surname>, <given-names>A.</given-names></string-name> <article-title>Adjusting batch effects in microarray expression data using empirical Bayes methods</article-title>. <source>Biostatistics</source> <volume>8</volume>, <fpage>1181</fpage>&#x2013;<lpage>127</lpage> (<year>2007</year>).</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Pawitan</surname>, <given-names>Y.</given-names></string-name> <etal>et al.</etal> <article-title>Gene expression profiling spares early breastcancer patients from adjuvant therapy: derived and validated in two population-based cohorts</article-title>. <source>Breast Cancer Res</source>. <volume>7</volume>, <fpage>R953</fpage>&#x2013;<lpage>64</lpage> (<year>2005</year>).</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="website"><article-title>International Genomics Consortium</article-title>. <source>Expression Project for Oncology</source>. Available at:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=gse2109">www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=gse2109</ext-link>. (<date-in-citation>Accessed: 28th July 2017</date-in-citation>)</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Phillips</surname>, <given-names>H. S.</given-names></string-name> <etal>et al.</etal> <article-title>Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis</article-title>. <source>Cancer Cell</source> <volume>9</volume>, <fpage>157</fpage>&#x2013;<lpage>173</lpage> (<year>2006</year>).</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Costa</surname>, <given-names>B. M.</given-names></string-name> <etal>et al.</etal> <article-title>Reversing HOXA9 Oncogene Activation by PI3K Inhibition: Epigenetic Mechanism and Prognostic Significance in Human Glioblastoma</article-title>. <source>Cancer Res</source>. <volume>70</volume>, <fpage>453</fpage>&#x2013;<lpage>462</lpage> (<year>2010</year>).</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Lu</surname>, <given-names>X.</given-names></string-name> <etal>et al.</etal> <article-title>Predicting features of breast cancer with gene expression patterns</article-title>. <source>Breast Cancer Res. Treat</source>. <volume>108</volume>, <fpage>191</fpage>&#x2013;<lpage>201</lpage> (<year>2008</year>).</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Miller</surname>, <given-names>W. R.</given-names></string-name> <etal>et al.</etal> <article-title>Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole. Pharmacogenet</article-title>. <source>Genomics</source><volume>17</volume>, <fpage>813</fpage>&#x2013;<lpage>826</lpage> (<year>2007</year>).</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Miller</surname>, <given-names>W. R.</given-names></string-name> &#x0026; <string-name><surname>Larionov</surname>, <given-names>A.</given-names></string-name> <article-title>Changes in expression of oestrogen regulated and proliferation genes with neoadjuvant treatment highlight heterogeneity of clinical resistance to the aromatase inhibitor, letrozole</article-title>. <source>Breast Cancer Res</source>. <volume>12</volume>, <fpage>R52</fpage> (<year>2010</year>).</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Loi</surname>, <given-names>S.</given-names></string-name> <etal>et al</etal>. <article-title>Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade</article-title>. <source>J. Clin. Oncol</source>. <volume>25</volume>, <fpage>1239</fpage>&#x2013;<lpage>1246</lpage> (<year>2007</year>).</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Huang</surname>, <given-names>C.-C.</given-names></string-name> <etal>et al.</etal> <article-title>Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children&#x2019;s Oncology Group</article-title>. <source>Clin. Cancer Res</source>. <volume>15</volume>, <fpage>1770</fpage>&#x2013;<lpage>1778</lpage> (<year>2009</year>).</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Kurian</surname>, <given-names>S. M.</given-names></string-name> <etal>et al.</etal> <article-title>Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling</article-title>. <source>Am. J. Transplant</source> <volume>14</volume>, <fpage>1164</fpage>&#x2013;<lpage>1172</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Lu</surname>, <given-names>T.-P.</given-names></string-name> <etal>et al.</etal> <article-title>Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking women</article-title>. <source>Cancer Epidemiol. Biomarkers Prev</source>. <volume>19</volume>, <fpage>2590</fpage>&#x2013;<lpage>2597</lpage> (<year>2010</year>).</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Miller</surname>, <given-names>W. R.</given-names></string-name>, <string-name><surname>Larionov</surname>, <given-names>HA.</given-names></string-name>, <string-name><surname>Anderson</surname>, <given-names>T. J.</given-names></string-name>, <string-name><surname>Evans</surname>, <given-names>D. B.</given-names></string-name> &#x0026; <string-name><surname>Dixon</surname>, <given-names>J. M.</given-names></string-name> <article-title>Sequential changes in gene expression profiles in breast cancers during treatment with the aromatase inhibitor, letrozole</article-title>. <source>Pharmacogenomics J</source>. <volume>12</volume>, <fpage>10</fpage>&#x2013;<lpage>21</lpage> (<year>2012</year>).</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Rotunno</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal> <article-title>A gene expression signature from peripheral whole blood for stage I lung adenocarcinoma</article-title>. <source>Cancer Prev. Res</source>. <volume>4</volume>, <fpage>1599</fpage>&#x2013;<lpage>1608</lpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Tsukamoto</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal> <article-title>Clinical significance of osteoprotegerin expression in human colorectal cancer</article-title>. <source>Clin. Cancer Res</source>. <volume>17</volume>, <fpage>2444</fpage>&#x2013;<lpage>2450</lpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Alter</surname>, <given-names>M. D.</given-names></string-name> <etal>et al.</etal> <article-title>Autism and increased paternal age related changes in global levels of gene expression regulation</article-title>. <source>PLoS One</source> <volume>6</volume>, <fpage>e16715</fpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Vilar</surname>, <given-names>E.</given-names></string-name> <etal>et al.</etal> <article-title>MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers</article-title>. <source>Cancer Res</source>. <volume>71</volume>, <fpage>2632</fpage>&#x2013;<lpage>2642</lpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Sanz-Pamplona</surname><given-names>R.</given-names></string-name> <etal>et al.</etal> <article-title>Gene expression differences between colon and rectum tumors</article-title>. <source>Clin. Cancer Res</source>. <volume>17</volume>, <fpage>7303</fpage>&#x2013;<lpage>7312</lpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Schmit</surname>, <given-names>S. L.</given-names></string-name> <etal>et al.</etal> <article-title>MicroRNA polymorphisms and risk of colorectal cancer</article-title>. <source>Cancer Epidemiol. Biomarkers Prev</source>. <volume>24</volume>, <fpage>65</fpage>&#x2013;<lpage>72</lpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>TWitt</surname>, <given-names>H.</given-names></string-name> <etal>et al.</etal> <article-title>Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma</article-title>. <source>Cancer Cell</source> <volume>20</volume>, <fpage>143</fpage>&#x2013;<lpage>157</lpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Cui</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal> <article-title>An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer</article-title>. <source>Nucleic Acids Res</source>. <volume>39</volume>, <fpage>1197</fpage>&#x2013;<lpage>1207</lpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Cui</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal> <article-title>Gene-expression signatures can distinguish gastric cancer grades and stages</article-title>. <source>PLoS One</source> <volume>6</volume>, <fpage>e17819</fpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Kikuchi</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal> <article-title>Identification of NUCKS1 as a colorectal cancer prognostic marker through integrated expression and copy number analysis</article-title>. <source>Int. J. Cancer</source> <volume>132</volume>, <fpage>2295</fpage>&#x2013;<lpage>2302</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Rousseaux</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal> <article-title>Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers</article-title>. <source>Sci. Transl. Med</source>. <volume>5</volume>, <fpage>186</fpage>ra<lpage>66</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Chen</surname>, <given-names>C.</given-names></string-name> <etal>et al.</etal> <article-title>Gene expression profiling identifies genes predictive of oral squamous cell carcinoma</article-title>. <source>Cancer Epidemiol. Biomarkers Prev</source>. <volume>17</volume>, <fpage>2152</fpage>&#x2013;<lpage>2162</lpage> (<year>2008</year>).</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Miyake</surname>, <given-names>T.</given-names></string-name> <etal>et al.</etal> <article-title>GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer</article-title>. <source>Cancer Sci</source>. <volume>103</volume>, <fpage>913</fpage>&#x2013;<lpage>920</lpage> (<year>2012</year>).</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Steiling</surname>, <given-names>K.</given-names></string-name> <etal>et al.</etal> <article-title>A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment</article-title>. <source>Am. J. Respir. Crit. Care Med</source>. <volume>187</volume>, <fpage>933</fpage>&#x2013;<lpage>942</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Olmos</surname>, <given-names>D.</given-names></string-name> <etal>et al.</etal> <article-title>Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study</article-title>. <source>Lancet Oncol</source>. <volume>13</volume>, <fpage>1114</fpage>&#x2013;<lpage>1124</lpage> (<year>2012</year>).</mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>Botling</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal> <article-title>Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation</article-title>. <source>Clin. Cancer Res</source>. <volume>19</volume>, <fpage>194</fpage>&#x2013;<lpage>204</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Laibe</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal> <article-title>A seven-gene signature aggregates a subgroup of stage II colon cancers with stage III</article-title>. <source>OMICS</source> <volume>16</volume>, <fpage>560</fpage>&#x2013;<lpage>565</lpage> (<year>2012</year>).</mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="journal"><string-name><surname>Huang</surname>, <given-names>L. S.</given-names></string-name> <etal>et al.</etal> <article-title>Sphingosine-1-phosphate lyase is an endogenous suppressor of pulmonary fibrosis: role of S1P signalling and autophagy</article-title>. <source>Thorax</source> <volume>70</volume>, <fpage>1138</fpage>&#x2013;<lpage>1148</lpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="journal"><string-name><surname>Hyland</surname>, <given-names>P. L.</given-names></string-name> <etal>et al.</etal> <article-title>Global changes in gene expression of Barrett&#x2019;s esophagus compared to normal squamous esophagus and gastric cardia tissues</article-title>. <source>PLoS One</source> <volume>9</volume>, <fpage>e93219</fpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>Marisa</surname>, <given-names>L.</given-names></string-name> <etal>et al.</etal> <article-title>Gene expression classification of colon cancerinto molecular subtypes: characterization, validation, and prognostic value</article-title>. <source>PLoS Med</source>. <volume>10</volume>, <fpage>e1001453</fpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c57"><label>57.</label><mixed-citation publication-type="journal"><string-name><surname>Kabakchiev</surname>, <given-names>B.</given-names></string-name> &#x0026; <string-name><surname>Silverberg</surname>, <given-names>M. S.</given-names></string-name> <article-title>Expression quantitative trait loci analysis identifies associations between genotype and gene expression in human intestine</article-title>. <source>Gastroenterology</source> <volume>144</volume>, <issue>1488&#x2013;96</issue>, <fpage>1496.e1</fpage>&#x2013;<lpage>3</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c58"><label>58.</label><mixed-citation publication-type="journal"><string-name><surname>Xu</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal> <article-title>Dominant role of oncogene dosage and absence of tumor suppressor activity in Nras-driven hematopoietic transformation</article-title>. <source>Cancer Discov</source>. <volume>3</volume>, <fpage>993</fpage>&#x2013;<lpage>1001</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Clelland</surname>, <given-names>C. L.</given-names></string-name> <etal>et al.</etal> <article-title>Utilization of never-medicated bipolar disorder patients towards development and validation of a peripheral biomarker profile</article-title>. <source>PLoS One</source> <volume>8</volume>, <fpage>e69082</fpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c60"><label>60.</label><mixed-citation publication-type="journal"><string-name><surname>Zhao</surname>, <given-names>S. G.</given-names></string-name> <etal>et al.</etal> <article-title>The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer</article-title>. <source>Clin. Cancer Res</source>. <volume>22</volume>, <fpage>1777</fpage>&#x2013;<lpage>1786</lpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="c61"><label>61.</label><mixed-citation publication-type="journal"><string-name><surname>Bessho</surname>, <given-names>K.</given-names></string-name> <etal>et al.</etal> <article-title>Gene expression signature for biliary atresia and a role for interleukin-8 in pathogenesis of experimental disease</article-title>. <source>Hepatology</source> <volume>60</volume>, <fpage>211</fpage>&#x2013;<lpage>223</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c62"><label>62.</label><mixed-citation publication-type="journal"><string-name><surname>Huang</surname>, <given-names>C.-C.</given-names></string-name> <etal>et al.</etal> <article-title>Concurrent gene signatures for han chinese breast cancers</article-title>. <source>PLoS One</source> <volume>8</volume>, <fpage>e76421</fpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c63"><label>63.</label><mixed-citation publication-type="journal"><string-name><surname>Salas</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal> <article-title>Gene Expression Profiling of Desmoid Tumors by cDNA Microarrays and Correlation with Progression-Free Survival</article-title>. <source>Clin. Cancer Res</source>. <volume>21</volume>, <fpage>4194</fpage>&#x2013;<lpage>4200</lpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c64"><label>64.</label><mixed-citation publication-type="journal"><string-name><surname>Lisowska</surname>, <given-names>K. M.</given-names></string-name> <etal>et al.</etal> <article-title>Gene expression analysis in ovarian cancer - faults and hints from DNA microarray study</article-title>. <source>Front. Oncol</source>. <volume>4</volume>, <fpage>6</fpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c65"><label>65.</label><mixed-citation publication-type="journal"><string-name><surname>Kurian</surname>, <given-names>S. M.</given-names></string-name> <etal>et al.</etal> <article-title>Peripheral Blood Cell Gene Expression Diagnostic for Identifying Symptomatic Transthyretin Amyloidosis Patients: Male and Female Specific Signatures</article-title>. <source>Theranostics</source> <volume>6</volume>, <fpage>1792</fpage>&#x2013;<lpage>1809</lpage> (<year>2016</year>).</mixed-citation></ref>
</ref-list>
</back>
</article>